Financhill
Back

Gilead Sciences 10K Form

Sell
41

GILD
Gilead Sciences

Last Price:
69.97
Seasonality Move:
6.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive GILD News And Ratings

See the #1 stock for the next 7 days that we like better than GILD

GILD Financial Statistics

Sales & Book Value

Annual Sales: $27.12B
Cash Flow: $2.11B
Price / Cash Flow: 11.11
Annual Sales: $14.07
Price / Book: 4.97

Profitability

EPS (TTM): 0.36000
Net Income (TTM): $484M
Gross Margin: $20.62B
Return on Equity: 2.32%
Return on Assets: 0.79%

Gilead Sciences Earnings Forecast

Key Gilead Sciences Financial Ratios

  • The Gross Profit Margin over the past 33 years for GILD is 76.04%.
  • The Selling, General & Administrative Expenses for GILD have been equal to 22.46% of Gross Profit Margin.
  • The Research & Development expenses have been 21.09% of Revenue.
  • The Interest Expense is 16.66% of Operating Income.
  • The Net Earning history of GILD is 20.89% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 19 years.

Gilead Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: GILD
CUSIP: 375558
Website: gilead.com

Debt

Debt-to-Equity Ratio: 1.44
Current Ratio: 1.08
Quick Ratio: 0.72

Price-to-Earnings

Trailing P/E Ratio: 15.55
Forward P/E Ratio: 9.78

GILD Technical Analysis vs Fundamental Analysis

Sell
41
Gilead Sciences (GILD) is a Sell

Is Gilead Sciences a Buy or a Sell?

  • Gilead Sciences stock is rated a Sell
    The current Gilead Sciences [GILD] share price is $69.96. The Score for GILD is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.